Coursaget P - Search Results

1

In vitro gene transfer using human papillomavirus-like particles.

Touze A, Coursaget P. Touze A, et al. Among authors: coursaget p. Nucleic Acids Res. 1998 Mar 1;26(5):1317-23. doi: 10.1093/nar/26.5.1317. Nucleic Acids Res. 1998. PMID: 9469843 Free PMC article.

2

Inhibition of cervical cancer cell growth by human papillomavirus virus-like particles packaged with human papillomavirus oncoprotein short hairpin RNAs.

Bousarghin L, Touze A, Gaud G, Iochmann S, Alvarez E, Reverdiau P, Gaitan J, Jourdan ML, Sizaret PY, Coursaget PL. Bousarghin L, et al. Among authors: coursaget pl. Mol Cancer Ther. 2009 Feb;8(2):357-65. doi: 10.1158/1535-7163.MCT-08-0626. Epub 2009 Jan 27. Mol Cancer Ther. 2009. PMID: 19174559

3

Gene transfer using human polyomavirus BK virus-like particles expressed in insect cells.

Touzé A, Bousarghin L, Ster C, Combita AL, Roingeard P, Coursaget P. Touzé A, et al. Among authors: coursaget p. J Gen Virol. 2001 Dec;82(Pt 12):3005-3009. doi: 10.1099/0022-1317-82-12-3005. J Gen Virol. 2001. PMID: 11714977

4

Serologic response to human oncogenic papillomavirus types 16, 18, 31, 33, 39, 58 and 59 virus-like particles in colombian women with invasive cervical cancer.

Combita AL, Bravo MM, Touzé A, Orozco O, Coursaget P. Combita AL, et al. Among authors: coursaget p. Int J Cancer. 2002 Feb 20;97(6):796-803. doi: 10.1002/ijc.10153. Int J Cancer. 2002. PMID: 11857357

5

Detection of neutralizing antibodies against human papillomaviruses (HPV) by inhibition of gene transfer mediated by HPV pseudovirions.

Bousarghin L, Combita-Rojas AL, Touzé A, El Mehdaoui S, Sizaret PY, Bravo MM, Coursaget P. Bousarghin L, et al. Among authors: coursaget p. J Clin Microbiol. 2002 Mar;40(3):926-32. doi: 10.1128/JCM.40.3.926-932.2002. J Clin Microbiol. 2002. PMID: 11880418 Free PMC article.

6

Identification of two cross-neutralizing linear epitopes within the L1 major capsid protein of human papillomaviruses.

Combita AL, Touzé A, Bousarghin L, Christensen ND, Coursaget P. Combita AL, et al. Among authors: coursaget p. J Virol. 2002 Jul;76(13):6480-6. doi: 10.1128/jvi.76.13.6480-6486.2002. J Virol. 2002. PMID: 12050360 Free PMC article.

7

Positively charged sequences of human papillomavirus type 16 capsid proteins are sufficient to mediate gene transfer into target cells via the heparan sulfate receptor.

Bousarghin L, Touzé A, Combita-Rojas AL, Coursaget P. Bousarghin L, et al. Among authors: coursaget p. J Gen Virol. 2003 Jan;84(Pt 1):157-164. doi: 10.1099/vir.0.18789-0. J Gen Virol. 2003. PMID: 12533712

8

Positively charged synthetic peptides from structural proteins of papillomaviruses abrogate human papillomavirus infectivity.

Bousarghin L, Touzé A, Yvonnet B, Coursaget P. Bousarghin L, et al. Among authors: coursaget p. J Med Virol. 2004 Jul;73(3):474-80. doi: 10.1002/jmv.20114. J Med Virol. 2004. PMID: 15170645

9

Mutations on the FG surface loop of human papillomavirus type 16 major capsid protein affect recognition by both type-specific neutralizing antibodies and cross-reactive antibodies.

Carpentier GS, Fleury MJ, Touzé A, Sadeyen JR, Tourne S, Sizaret PY, Coursaget P. Carpentier GS, et al. Among authors: coursaget p. J Med Virol. 2005 Dec;77(4):558-65. doi: 10.1002/jmv.20492. J Med Virol. 2005. PMID: 16254978

10

Human papillomavirus type 16 pseudovirions with few point mutations in L1 major capsid protein FG loop could escape actual or future vaccination for potential use in gene therapy.

Fleury MJ, Touzé A, Coursaget P. Fleury MJ, et al. Among authors: coursaget p. Mol Biotechnol. 2014 May;56(5):479-86. doi: 10.1007/s12033-014-9745-1. Mol Biotechnol. 2014. PMID: 24639327 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

205 results

Search Page

Filters